Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 13, 2018

SELL
$3.2 - $4.7 $1,046 - $1,536
-327 Reduced 81.75%
73 $0
Q1 2018

May 11, 2018

SELL
$2.55 - $4.85 $254 - $484
-100 Reduced 20.0%
400 $1,000
Q4 2017

Feb 13, 2018

SELL
$3.5 - $5.65 $7,000 - $11,300
-2,000 Reduced 80.0%
500 $2,000
Q3 2017

Nov 13, 2017

BUY
$4.5 - $5.65 $11,250 - $14,125
2,500
2,500 $13,000

About Adamis Pharmaceuticals Corp


  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Winch Advisory Services, LLC Portfolio

Follow Winch Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winch Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winch Advisory Services, LLC with notifications on news.